Furthermore, we also detected the expression levels of FEZF1 in the same cohort of 34 paired tissue samples using real-time PCR, the results indicated that FEZF1 expression levels in tumor tissues of CRC patients were significantly higher than those in corresponding normal tissues (p < 0.05, Figure 5E). This evidence concerns the gene FEZF1 and neoplasm.